Login / Signup

Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.

Elizabeth Hope WeisslerRobert M ClareYuliya LokhnyginaJohn B BuseShaun G GoodmanBrian KatonaNayyar IqbalNeha J PagidipatiNaveed SattarRury R HolmanAdrian F HernandezRobert J MentzManesh R PatelW Schuyler Jones
Published in: Diabetic medicine : a journal of the British Diabetic Association (2021)
The majority of MALE occurred among participants with PAD, but participants without a history of PAD also experienced MALE. A risk score with good performance was generated. Although it requires validation in an external dataset, this risk score may be valuable in identifying patients requiring more intensive care and closer follow-up.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • clinical trial
  • study protocol
  • emergency department
  • patient reported outcomes
  • phase ii
  • open label
  • double blind